Vanguard Group
NARI

Vanguard Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Vanguard Group’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,628,875
Closed -$287M – 4327
2024
Q4 		$287M Buy
5,628,875
+30,702
+0.5% +$1.51M 0.01% 1366
2024
Q3 		$231M Sell
5,598,173
-30,602
-0.5% -$1.47M ﹤0.01% 1473
2024
Q2 		$271M Buy
5,628,775
+28,921
+0.5% +$1.28M 0.01% 1324
2024
Q1 		$269M Buy
5,599,854
+561,562
+11% +$30M 0.01% 1343
2023
Q4 		$327M Buy
5,038,292
+325,586
+7% +$19.6M 0.01% 1234
2023
Q3 		$308M Sell
4,712,706
-36,096
-0.8% -$2.27M 0.01% 1188
2023
Q2 		$276M Buy
4,748,802
+352,398
+8% +$22.2M 0.01% 1292
2023
Q1 		$271M Buy
4,396,404
+64,975
+2% +$3.9M 0.01% 1279
2022
Q4 		$275M Buy
4,331,429
+88,191
+2% +$6.39M 0.01% 1243
2022
Q3 		$308M Buy
4,243,238
+242,983
+6% +$18.1M 0.01% 1115
2022
Q2 		$272M Buy
4,000,255
+481,609
+14% +$34.6M 0.01% 1242
2022
Q1 		$319M Buy
3,518,646
+416,425
+13% +$34.1M 0.01% 1259
2021
Q4 		$283M Buy
3,102,221
+200,989
+7% +$17.2M 0.01% 1388
2021
Q3 		$235M Buy
2,901,232
+387,349
+15% +$32.5M 0.01% 1505
2021
Q2 		$234M Buy
2,513,883
+433,521
+21% +$42M 0.01% 1537
2021
Q1 		$223M Buy
2,080,362
+540,393
+35% +$56.1M 0.01% 1526
2020
Q4 		$134M Buy
1,539,969
+714,040
+86% +$50.4M ﹤0.01% 1680
2020
Q3 		$57M Buy
825,929
+316,184
+62% +$20.3M ﹤0.01% 1945
2020
Q2 		$24.7M Buy
+509,745
New +$24.3M ﹤0.01% 2318

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $426M AUM 23.62% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Vanguard Group's NARI Position: Q1 2025 in Review

Vanguard Group sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 5,628,875 shares — an estimated $287M sold.

Vanguard Group first reported a position in NARI in Q2 2020 and held it in 19 quarters. The position peaked at $327M in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Vanguard Group reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Vanguard Group sold 5,628,875 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $287M.
  • Vanguard Group first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 19 quarters.
  • Vanguard Group's Inari Medical, Inc. Common Stock position peaked at $327M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.